Quarterly report pursuant to Section 13 or 15(d)

Note 8 - Accrued Liabilities - Accrued Liabilities (Details)

v3.24.1.u1
Note 8 - Accrued Liabilities - Accrued Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Clinical trial costs $ 689 $ 258
Research and development services 637 632
Compensation 317 766
Professional services fees 150 98
Other 22 23
Total accrued liabilities $ 1,815 $ 1,777